Trupanion (TRUP) Downgraded by Zacks Investment Research

Trupanion (NASDAQ:TRUP) was downgraded by Zacks Investment Research from a “hold” rating to a “strong sell” rating in a report issued on Thursday.

According to Zacks, “Trupanion, Inc. operates as a direct-to-consumer monthly subscription service provider of a medical insurance plan for cats and dogs. It operates primarily in Canada, Puerto Rico, and the United States. The Company serves pet owners and veterinarians. Trupanion, Inc. is headquartered in Seattle, Washington. “

A number of other brokerages have also commented on TRUP. Lake Street Capital upped their price objective on shares of Trupanion from $32.00 to $41.00 and gave the company a “buy” rating in a research report on Wednesday, February 14th. BidaskClub raised shares of Trupanion from a “hold” rating to a “buy” rating in a research report on Monday, December 18th. Stifel Nicolaus reissued a “buy” rating and issued a $34.00 price target (up previously from $33.00) on shares of Trupanion in a research report on Wednesday, February 14th. Northland Securities reissued a “buy” rating and issued a $38.00 price target on shares of Trupanion in a research report on Thursday, February 8th. Finally, ValuEngine raised shares of Trupanion from a “hold” rating to a “buy” rating in a research report on Monday, April 2nd. Two equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and seven have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $35.57.



Shares of TRUP traded up $0.04 during trading hours on Thursday, reaching $26.83. 284,094 shares of the company traded hands, compared to its average volume of 367,285. The firm has a market capitalization of $786.65, a P/E ratio of -383.29 and a beta of 0.57. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.89 and a current ratio of 1.89. Trupanion has a 1-year low of $14.27 and a 1-year high of $37.13.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings data on Tuesday, February 13th. The financial services provider reported ($0.05) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.02) by ($0.03). The company had revenue of $66.55 million for the quarter, compared to analyst estimates of $65.60 million. Trupanion had a negative net margin of 0.62% and a negative return on equity of 6.66%. equities analysts forecast that Trupanion will post -0.05 earnings per share for the current year.

In other news, insider Darryl Rawlings sold 4,000 shares of the firm’s stock in a transaction that occurred on Monday, March 26th. The shares were sold at an average price of $29.71, for a total transaction of $118,840.00. Following the completion of the sale, the insider now owns 1,371,976 shares of the company’s stock, valued at $40,761,406.96. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Murray B. Low sold 3,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 22nd. The stock was sold at an average price of $28.42, for a total transaction of $85,260.00. Following the sale, the director now directly owns 194,281 shares of the company’s stock, valued at approximately $5,521,466.02. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 21,000 shares of company stock valued at $654,865. Company insiders own 31.24% of the company’s stock.

Several institutional investors and hedge funds have recently added to or reduced their stakes in TRUP. Millennium Management LLC bought a new stake in shares of Trupanion during the fourth quarter valued at approximately $6,851,000. BlackRock Inc. boosted its stake in Trupanion by 15.2% in the fourth quarter. BlackRock Inc. now owns 1,310,881 shares of the financial services provider’s stock valued at $38,370,000 after acquiring an additional 172,785 shares during the last quarter. DAVENPORT & Co LLC boosted its stake in Trupanion by 199.3% in the fourth quarter. DAVENPORT & Co LLC now owns 188,770 shares of the financial services provider’s stock valued at $5,525,000 after acquiring an additional 125,707 shares during the last quarter. The Manufacturers Life Insurance Company boosted its stake in Trupanion by 647.6% in the fourth quarter. The Manufacturers Life Insurance Company now owns 134,997 shares of the financial services provider’s stock valued at $3,951,000 after acquiring an additional 116,940 shares during the last quarter. Finally, Two Sigma Investments LP boosted its stake in Trupanion by 63.1% in the fourth quarter. Two Sigma Investments LP now owns 200,552 shares of the financial services provider’s stock valued at $5,870,000 after acquiring an additional 77,567 shares during the last quarter. 74.75% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: “Trupanion (TRUP) Downgraded by Zacks Investment Research” was reported by Dakota Financial News and is the property of of Dakota Financial News. If you are reading this piece of content on another site, it was copied illegally and republished in violation of US & international copyright and trademark laws. The correct version of this piece of content can be viewed at https://dakotafinancialnews.com/2018/04/12/trupanion-trup-downgraded-by-zacks-investment-research.html.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.

Get a free copy of the Zacks research report on Trupanion (TRUP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply